During a recent government meeting, significant concerns were raised regarding the public health implications of marijuana commercialization in San Diego County. A health advocate highlighted alarming research indicating that marijuana use nearly doubles the risk of heart attacks and strokes, particularly among seniors who are already at higher risk for cardiovascular issues. The advocate emphasized that despite perceptions of marijuana as a natural and safe substance, it poses serious health risks, including a threefold increase in the likelihood of serious cardiovascular events and a fivefold increase in the risk of psychosis with regular use of high-potency marijuana.
The advocate cautioned against expanding marijuana facilities in San Diego, arguing that such actions could mislead youth into perceiving marijuana as safe, ultimately jeopardizing the health of the community. The call to action underscored the need for careful consideration of the long-term public health impacts associated with marijuana commercialization.
Following this, Kathleen Lippitt from the Department of Cannabis Control (DCC) addressed concerns regarding the safety and regulation of cannabis products. She reported that testing facilities responsible for ensuring cannabis products were free from harmful contaminants had failed to meet permit requirements. This oversight was exacerbated by the dismissal of a whistleblower who had raised alarms about the presence of banned pesticides in products sold to consumers.
Lippitt criticized the DCC for its inadequate oversight, noting that unethical testing practices have become prevalent, particularly in states lacking rigorous regulatory verification. She pointed out that quality testing labs that maintained ethical standards often went out of business due to unfair competition from those that compromised on safety.
The meeting concluded with Lippitt expressing disappointment over the board's increasing tendency to restrict dissenting opinions, highlighting a growing concern about transparency and accountability in the regulation of cannabis in the region.